L
atin American researchers have played a central role in tobacco control research for almost a century. An obscure scientist from Argentina named Angel Honorio Roffo was one of the first in the world to draw attention to the link between smoking and cancer. 1 Roffo pioneering work in tobacco carcinogenesis beginning in the 1920's helped establish that chemicals in tobacco tar caused cancer. Animal experiments conducted by Roffo testing different fractions of tobacco smoke condensate helped establish that tar rather than nicotine was the cause of cancer, and that polycyclic aromatic hydrocarbons found in the tar were one of the classes of chemicals in tobacco smoke responsible for cancer formation. 1 Most of Roffo's work was published prior to 1940, long before the more widely publicized smoking and health epidemiological and experimental studies of the early 1950's by American and British scientists. [2] [3] [4] [5] [6] [7] As illustrated by the papers in this special issue of Salud Pública de México, tobacco control research in Latin America has come full circle from the early work by Roffo which focused on tobacco as a cause of disease, to the current focus on evaluating the most effective interventions to reduce tobacco consumption. While Roffo would likely be saddened to know that it has taken the world so long to act upon his research on tobacco and cancer, he would no doubt be pleased to see the concerted efforts now being made under the auspices of the World Health Organization's Framework Convention on Tobacco Control (FCTC) to formulate a global movement to reduce the harm caused by tobacco use. 8 The FCTC is the first-ever international public health treaty, which obligates ratifying countries to broad, comprehensive tobacco control policies such as high taxes on tobacco products, complete advertising bans, enhanced pack warnings, mass media campaigns, and 100% smoke-free policies.
The FCTC has propelled tobacco control into a new era as countries all over the world consider incorporat-EDITORIAL Latin America: a laboratory for tobacco control research ing FCTC policies and recommendations into their own legislation. 9 This is a time of great promise and great challenge. As tobacco control policies are formulated and implemented, it is important that policies undergo rigorous evaluation. As the FCTC continues into its critical implementation phase over the next decade -as each of the almost 170 nations around the world that have ratified the treaty decide what specific policies will be implemented to meet their treaty obligations-it is becoming increasingly important that stronger scientific evidence is needed to guide individual countries to adopt policies that will work effectively. 10, 11 Latin American countries are at the forefront of implementing FCTC policies as illustrated in table 1. The articles presented in this supplement represent the first wave of research evidence emerging from studies evaluating the effectiveness and the challenges of implementing the FCTC in Latin America. As illustrated by several of the papers in this supplement, we are already beginning to see how the tobacco industry is working to undermine the FCTC by encouraging countries to adopt policies that, although compliant with the FCTC, are suboptimal. [12] [13] [14] [15] [16] [17] [18] Governments will also need to be ready to evolve and change their policies in order to ensure they achieve their goals, as Honduras has recently done to explicitly exclude tobacco industry involvement in policy making on tobacco control following the recommendations of FCTC's Article 5.3. 19 However, limiting the influence of the tobacco industry will not be an easy task as the tobacco companies continue to wield enormous economic and politic influence in the region.
Latin America has become an important laboratory for learning about what policies and programs work in reducing the harm caused by tobacco. Over the next few years as existing tobacco control policies are refined and new ones are implemented, it is critically important for the public health community to devote attention and resources to evaluate what is working, salud pública de méxico / vol. 52, suplemento 2 de 2010 and what is not. Good public health practice, the same as clinical medicine, demands evidence from rigorously conducted evaluation research to guide the adoption of evidence based interventions as well as to aid in the discovery of new and more effective interventions. The Latin American region is uniquely positioned to play a prominent role in helping guide public health efforts to stem the global epidemic of premature deaths caused by tobacco. 
